Journal of Allergy and Clinical Immunology-In Practice

Article	Citations
Telemedicine in the Era of COVID-19	420
mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach	317
COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic	225
A Consensus Approach to the Primary Prevention of Food Allergy Through Nutrition: Guidance from the American Academy of Allergy, Asthma, and Immunology; American College of Allergy, Asthma, and Immuno	165
US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema	156
Chronic Rhinosinusitis with Nasal Polyps and Asthma	148
Polyethylene Glycol–Induced Systemic Allergic Reactions (Anaphylaxis)	147
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach	146
Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic	140
Global Trends in Anaphylaxis Epidemiology and Clinical Implications	136
Exercise and Fitness in the Age of Social Distancing During the COVID-19 Pandemic	129
Clinician Wellness During the COVID-19 Pandemic: Extraordinary Times and Unusual Challenges for the Allergist/Immunologist	126
Risk Communication During COVID-19	126
Initial effects of the COVID-19 pandemic on pediatric asthma emergency department utilization	122
Prevalence of Food Sensitization and Food Allergy in Children Across Europe	109
Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden	109
Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness	108
Prevalence of Comorbid Asthma and Related Outcomes in COVID-19: A Systematic Review and Meta-Analysis	101
First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing	101
Long-Term Therapy Response to Anti–IL-5 Biologics in Severe Asthma—A Real-Life Evaluation	100
Pediatric Asthma Health Care Utilization, Viral Testing, and Air Pollution Changes During the COVID-19 Pandemic	100
Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs	99
Asthma prolongs intubation in COVID-19	96
Overview of STING-Associated Vasculopathy with Onset in Infancy (SAVI) Among 21 Patients	96
Food Allergy from Infancy Through Adulthood	91

Anti-PEG IgE in anaphylaxis associated with polyethylene glycol	83
Benralizumab as a Steroid-Sparing Treatment Option in Eosinophilic Granulomatosis with Polyangiitis	79
The Impact of Social Determinants of Health on Children with Asthma	79
Artificial Intelligence/Machine Learning in Respiratory Medicine and Potential Role in Asthma and COPD Diagnosis	78
The Challenges and Opportunities for Shared Decision Making Highlighted by COVID-19	76
Temporal trends in prevalence of food allergy in Canada	76
SARS-CoV-2 Pneumonia in Hospitalized Asthmatic Patients Did Not Induce Severe Exacerbation	72
Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis	71
Endophenotypic Variations of Atopic Dermatitis by Age, Race, and Ethnicity	71
Biologics for Treatment of Atopic Dermatitis: Current Status and Future Prospect	69
Improving Diagnostic Accuracy in Food Allergy	69
Hereditary Alpha-Tryptasemia: UK Prevalence and Variability in Disease Expression	69
Clinical Relevance of Cross-Reactivity in Food Allergy	69
Phenotypes of Chronic Rhinosinusitis	68
Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma	67
Defining a Severe Asthma Super-Responder: Findings from a Delphi Process	67
Rapid recovery of a SARS-CoV-2–infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma	66
Systematic Review of Digital Interventions for Pediatric Asthma Management	64
Clinical outcomes and features of COVID-19 in patients with primary immunodeficiencies in New York City	64
Endotypes of Chronic Rhinosinusitis with Nasal Polyps: Pathology and Possible Therapeutic Implications	63
Biologics for the Use in Chronic Spontaneous Urticaria: When and Which	62
Real-World Effectiveness of Omalizumab in Severe Allergic Asthma: A Meta-Analysis of Observational Studies	62
The Pathogenesis of Chronic Spontaneous Urticaria: The Role of Infiltrating Cells	62
Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes	61
Health-Related Quality of Life in Common Variable Immunodeficiency Italian Patients Switched to Remote Assistance During the COVID-19 Pandemic	61
Emerging Causes of Drug-Induced Anaphylaxis: A Review of Anaphylaxis-Associated Reports in the FDA Adverse Event Reporting System (FAERS)	60
Trends in hospitalizations for asthma during the COVID-19 outbreak in Japan	59
COVID-19 Susceptibility in Bronchial Asthma	59
Work Group Report: COVID-19: Unmasking Telemedicine	58
Reduction of allergic rhinitis symptoms with face mask usage during the COVID-19 pandemic	57
Comparative Study of Food Allergies in Children from China, India, and Russia: The EuroPrevall-INCO Surveys	55
Impact of Allergic Rhinitis and Asthma on COVID-19 Infection, Hospitalization, and Mortality	54
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity	54
Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis	54
Penicillin Allergy Delabeling: A Multidisciplinary Opportunity	53
Complications of switching from anti–IL-5 or anti–IL-5R to dupilumab in corticosteroid-dependent severe asthma	53
The Unexpected Risks of COVID-19 on Asthma Control in Children	52
Epidemiology of Chronic Rhinosinusitis: Prevalence and Risk Factors	52
Digital Health Technology in Asthma: A Comprehensive Scoping Review	52
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study	52
Cluster Analysis of Inflammatory Biomarker Expression in the International Severe Asthma Registry	51
Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps	51
Different Measures of Diet Diversity During Infancy and the Association with Childhood Food Allergy in a UK Birth Cohort Study	51
Integrated Safety and Efficacy Among Patients Receiving Benralizumab for Up to 5 Years	50
Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: General Concepts	49
Immunological Responses and Biomarkers for Allergen-Specific Immunotherapy Against Inhaled Allergens	48
Validation of the Angioedema Control Test (AECT)—A Patient-Reported Outcome Instrument for Assessing Angioedema Control	48
Prospective Assessment of Pediatrician-Diagnosed Food Protein–Induced Allergic Proctocolitis by Gross or Occult Blood	48
The Prevalence of Subtypes of Type 2 Inflammation in an Unselected Population of Patients with Severe Asthma	48
Primary Immunodeficiency Diseases and Bacillus Calmette-Guérin (BCG)-Vaccine–Derived Complications: A Systematic Review	47

Clinical, Immunological, and Genetic Features in Patients with Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked (IPEX) and IPEX-like Syndrome	46
Novel Approaches to Food Allergy Management During COVID-19 Inspire Long-Term Change	46
An Approach to the Office-Based Practice of Food Oral Immunotherapy	46
Rhinovirus Infections and Their Roles in Asthma: Etiology and Exacerbations	46
Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection	46
Which Are the Optimal Criteria for the Diagnosis of Allergic Bronchopulmonary Aspergillosis? A Latent Class Analysis	46
Earlier aggressive treatment to shorten the duration of eczema in infants resulted in fewer food allergies at 2 years of age	45
Use and Interpretation of Acute and Baseline Tryptase in Perioperative Hypersensitivity and Anaphylaxis	45
Dupilumab Improves Asthma Control and Lung Function in Patients with Insufficient Outcome During Previous Antibody Therapy	44
Geospatial Analysis of Social Determinants of Health Identifies Neighborhood Hot Spots Associated With Pediatric Intensive Care Use for Life-Threatening Asthma	43
Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak	43
Prevalence and Burden of Chronic Cough in the United States	43
Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps	43
First Real-World Effectiveness Analysis of Preschool Peanut Oral Immunotherapy	42
Potential Severe Asthma Hidden in UK Primary Care	42
Urticaria and Angioedema Across the Ages	42
Effectiveness of myAirCoach: A mHealth Self-Management System in Asthma	42
Epinephrine in the Management of Anaphylaxis	42
Acute At Home Management of Anaphylaxis During the Covid-19 Pandemic	42
2020 NAEPP Guidelines Update and GINA 2021—Asthma Care Differences, Overlap, and Challenges	41
Autoimmune Chronic Spontaneous Urticaria Detection with IgG Anti-TPO and Total IgE	41
Hidden Dangers: Recognizing Excipients as Potential Causes of Drug and Vaccine Hypersensitivity Reactions	41
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study	41
Small Airway Dysfunction Links Asthma Severity with Physical Activity and Symptom Control	41
Diagnostic Delay in Patients with Eosinophilic Gastritis and/or Duodenitis: A Population-Based Study	41
Epidemiology of Nonesophageal Eosinophilic Gastrointestinal Diseases in Symptomatic Patients: A Systematic Review and Meta-Analysis	41
Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19	40
Current and Future Treatments of Rhinitis and Sinusitis	40
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study	39
Impact of the COVID-19 pandemic in children with allergic asthma	38
The Genetic Basis and Clinical Impact of Hereditary Alpha-Tryptasemia	38
“Idiopathic Eosinophilic Vasculitis”: Another Side of Hypereosinophilic Syndrome? A Comprehensive Analysis of 117 Cases in Asthma-Free Patients	38
The Impact of Patient Self-Monitoring Via Electronic Medication Monitor and Mobile App Plus Remote Clinician Feedback on Adherence to Inhaled Corticosteroids: A Randomized Controlled Trial	38
Community Use of Epinephrine for the Treatment of Anaphylaxis: A Review and Meta-Analysis	38
The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma	37
A Slice of Food Protein–Induced Enterocolitis Syndrome (FPIES): Insights from 441 Children with FPIES as Provided by Caregivers in the International FPIES Association	37
Age-Related Differences in Immunological Responses to SARS-CoV-2	37
Penicillin Allergy Assessment in Pregnancy: Safety and Impact on Antibiotic Use	37
Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series	36
Chronic Rhinosinusitis With Nasal Polyps: Quality of Life in the Biologics Era	36
Anaphylaxis to PEGylated liposomal echocardiogram contrast in a patient with IgE-mediated macrogol allergy	36
Asthma and Three Colinear Comorbidities: Obesity, OSA, and GERD	36
Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics: A National Institute of Allergy and Infectious Diseases Workshop	36
COVID-19 Vaccination in Patients with Reported Allergic Reactions: Updated Evidence and Suggested Approach	36
SARS-CoV-2 Vaccines: Where Are We Now?	36
Weathering the Cytokine Storm in Susceptible Patients with Severe SARS-CoV-2 Infection	36
Prevalence and Characteristics of Shellfish Allergy in the Pediatric Population of the United States	35
Basophil Activation Test Reduces Oral Food Challenges to Nuts and Sesame	35
A Practical Guide to Implementing SMART in Asthma Management	35
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User’s Guide for Daily Clinical Practice	35
COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab	35
Innate and Adaptive Immunity: ILC2 and Th2 Cells in Upper and Lower Airway Allergic Diseases	34
Risk Factors and Characteristics of Biphasic Anaphylaxis	34
The Expanding Spectrum of Mutations in Hereditary Angioedema	34
Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America	34
Burden of Specialist-Diagnosed Chronic Cough in Adults	34
Treatable Traits That Predict Health Status and Treatment Response in Airway Disease	34
The Relationship of Asthma Biologics to Remission for Asthma	33
Improvements in Quality of Life in Children Following Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in the PEPITES and PEOPLE Studies	33
Sleep Disturbances and Atopic Dermatitis: Relationships, Methods for Assessment, and Therapies	33
Endophenotyping Oxaliplatin Hypersensitivity: Personalizing Desensitization to the Atypical Platin	32
Trajectory Analyses of Adherence Patterns in a Real-Life Moderate to Severe Asthma Population	32
Persistent Viral Presence Determines the Clinical Course of the Disease in COVID-19	32
Pragmatic Clinical Perspective on Biologics for Severe Refractory Type 2 Asthma	32
FEF25-75% Is a More Sensitive Measure Reflecting Airway Dysfunction in Patients with Asthma: A Comparison Study Using FEF25-75% and FEV1%	32
Direct Challenges to Penicillin-Based Antibiotics in the Inpatient Setting	32
Long-term follow-up and treatment outcomes of conjunctivitis during dupilumab treatment in patients with moderate-to-severe atopic dermatitis	32
Comparison of Different Biologics for Treating Chronic Rhinosinusitis With Nasal Polyps: A Network Analysis	31
Effect of COVID-19 on asthma exacerbation	31
Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results	31
Asthma Disease Status, COPD, and COVID-19 Severity in a Large Multiethnic Population	31
Benralizumab Completely Depletes Gastrointestinal Tissue Eosinophils and Improves Symptoms in Eosinophilic Gastrointestinal Disease	31
Lower Use of Biologics for the Treatment of Asthma in Publicly Insured Individuals	31
Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review	31
Alopecia Areata Is Associated with Atopic Diathesis: Results from a Population-Based Study of 51,561 Patients	31
Appraisal of the Real-World Effectiveness of Biologic Therapies in Aspirin-Exacerbated Respiratory Disease	31
Dupilumab Improves Asthma and Sinonasal Outcomes in Adults with Moderate to Severe Atopic Dermatitis	30
COVID-19 infection in 10 common variable immunodeficiency patients in New York City	30
Translating Evidence to Optimize Patient Care Using GRADE	30
Allergens and Adjuvants in Allergen Immunotherapy for Immune Activation, Tolerance, and Resilience	30

Serum Eosinophil-Derived Neurotoxin Better Reflect Asthma Control Status Than Blood Eosinophil Counts	30
Targeting Downstream Type 2 Cytokines or Upstream Epithelial Alarmins for Severe Asthma	30
Efficacy and Safety of Ragweed SLIT-Tablet in Children with Allergic Rhinoconjunctivitis in a Randomized, Placebo-Controlled Trial	30
Pediatric asthma exacerbations during the COVID-19 pandemic: Absence of the typical fall seasonal spike in Washington, DC	30
Risk of Psychiatric Adverse Events Among Montelukast Users	30
A Randomized, Open-Label Trial of Hen's Egg Oral Immunotherapy: Efficacy and Humoral Immune Responses in 50 Children	30
Systematic Assessment of Difficult-to-Treat Asthma: Principles and Perspectives	30
Bringing the Next Generation of Food Allergy Diagnostics Into the Clinic	30
COVID-19 affecting hereditary angioedema patients with and without C1 inhibitor deficiency	29
A Phased Approach to Resuming Suspended Allergy/Immunology Clinical Services	29
Advances in IgE Testing for Diagnosis of Allergic Disease	29
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM–Adjusted Proposal of the ECNM-AIM Consortium	29
Adverse Reactions Associated with Penicillins, Carbapenems, Monobactams, and Clindamycin: A Retrospective Population-based Study	29
Estimating COVID-19 Infection and Severity Risks in Patients with Chronic Rhinosinusitis: A Korean Nationwide Cohort Study	29
Comparison of Nonesophageal Eosinophilic Gastrointestinal Disorders with Eosinophilic Esophagitis: A Nationwide Survey	29
Biphasic Reactions in Emergency Department Anaphylaxis Patients: A Prospective Cohort Study	29
Advancing Food Allergy Through Epidemiology: Understanding and Addressing Disparities in Food Allergy Management and Outcomes	29
New Perspectives on Difficult Asthma; Sex and Age of Asthma-Onset Based Phenotypes	28
Effective Management of Severe Asthma with Biologic Medications in Adult Patients: A Literature Review and International Expert Opinion	28
Diagnosis of Sesame Allergy: Analysis of Current Practice and Exploration of Sesame Component Ses i 1	28
Clinical and Serological Characterization of the α-Gal Syndrome—Importance of Atopy for Symptom Severity in a European Cohort	28
Add-On Omalizumab for Inadequately Controlled Severe Pollinosis Despite Standard-of-Care: A Randomized Study	28
Chronic Respiratory Diseases and the Outcomes of COVID-19: A Nationwide Retrospective Cohort Study of 39,420 Cases	28
Risk Factors for Hen's Egg Allergy in Europe: EuroPrevall Birth Cohort	28
Disease-Modifying Effect of Japanese Cedar Pollen Sublingual Immunotherapy Tablets	28
Egg Allergy in US Children	28
Patient Satisfaction with In-Person, Video, and Telephone Allergy/Immunology Evaluations During the COVID-19 Pandemic	28
Establishing Amoxicillin Allergy in Children Through Direct Graded Oral Challenge (GOC): Evaluating Risk Factors for Positive Challenges, Safety, and Risk of Cross-Reactivity to Cephalosporines	28
Low Frequency of IgE-Mediated Food Hypersensitivity in Mastocytosis	28
Telemedical Asthma Education and Health Care Outcomes for School-Age Children: A Systematic Review	28
Managing Food Allergy When the Patient Is Not Highly Allergic	28
The Allergen: Sources, Extracts, and Molecules for Diagnosis of Allergic Disease	28
The Accuracy of Diagnostic Testing in Determining Tree Nut Allergy: A Systematic Review	27
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)	27
How to Assess Effectiveness of Biologics for Asthma and What Steps to Take When There Is Not Benefit	27
The COVID-19 Pandemic in 2021: Avoiding Overdiagnosis of Anaphylaxis Risk While Safely Vaccinating the World	27
Oral Corticosteroids and Risk of Preterm Birth in the California Medicaid Program	27
Personalized Treatment of Asthma: The Importance of Sex and Gender Differences	27
Usage Patterns of Short-Acting β2-Agonists and Inhaled Corticosteroids in Asthma: A Targeted Literature Review	27
Disconnect between effects of mepolizumab on severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps	27
Wheat Anaphylaxis in Adults Differs from Reactions to Other Types of Food	27
AAAAI Work Group Report: Trends in Oral Food Challenge Practices Among Allergists in the United States	27
Ascertainment Bias in Anaphylaxis Safety Data of COVID-19 Vaccines	27
Recent dramatic increase in patients with food protein–induced enterocolitis syndrome (FPIES) provoked by hen’s egg in Japan	27
Longitudinal Impact of Sputum Inflammatory Phenotypes on Small Airway Dysfunction and Disease Outcomes in Asthma	27
Systematic Assessment for Difficult and Severe Asthma Improves Outcomes and Halves Oral Corticosteroid Burden Independent of Monoclonal Biologic Use	26
Hypogammaglobulinemia After Chimeric Antigen Receptor (CAR) T-Cell Therapy: Characteristics, Management, and Future Directions	26
A Cost-Effectiveness Evaluation of Hospitalizations, Fatalities, and Economic Outcomes Associated with Universal Versus Anaphylaxis Risk-Stratified COVID-19 Vaccination Strategies	26
The Adoption and Implementation of Digital Health Care in the Post–COVID-19 Era	26
Importance of Adequate Diagnostic Workup for Correct Diagnosis of Advanced Systemic Mastocytosis	26
REALITI-A Study: Real-World Oral Corticosteroid-Sparing Effect of Mepolizumab in Severe Asthma	26
Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control Measure	26
A Cost-Effectiveness Analysis of Epinephrine Autoinjector Risk Stratification for Patients with Food Allergy—One Epinephrine Autoinjector or Two?	26
Collagen—An Important Fish Allergen for Improved Diagnosis	26
Peanut-induced food protein–induced enterocolitis syndrome (FPIES) in infants with early peanut introduction	26
Personalized Medication Adherence Management in Asthma and Chronic Obstructive Pulmonary Disease: A Review of Effective Interventions and Development of a Practical Adherence Toolkit	26
Rhinitis Phenotypes	26
A Systematic Review of the Effect of Physical Activity on Asthma Outcomes	26
Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2)	26
Disparities in Asthma and Allergy Care: What Can We Do?	26
Community Private Practice Clinical Experience with Peanut Oral Immunotherapy	26
Effect of Inhaled Corticosteroids on Exacerbation of Asthma-COPD Overlap According to Different Diagnostic Criteria	25
Effects of Aerobic Training Versus Breathing Exercises on Asthma Control: A Randomized Trial	25
Research Priorities in Pediatric Asthma: Results of a Global Survey of Multiple Stakeholder Groups by the Pediatric Asthma in Real Life (PeARL) Think Tank	25
Allergic symptoms after mRNA COVID-19 vaccination and risk of incomplete vaccination	25
Food Insecure and Allergic in a Pandemic: A Vulnerable Population	25
Clinical Profile and Treatment in Hypereosinophilic Syndrome Variants: A Pragmatic Review	25
Cigarette Smoking and Asthma	25
A Streamlined Approach to Optimize Perioperative Antibiotic Prophylaxis in the Setting of Penicillin Allergy Labels	25
Patient Characteristics and Risk Factors for Home Epinephrine-Treated Reactions During Oral Immunotherapy for Food Allergy	25
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma and Perennial Allergy	25
Ten Rules for Implementation of a Telemedicine Program to Care for Patients with Asthma	25
Controversies in Allergy: Chemotherapy Reactions, Desensitize, or Delabel?	25
The Psychosocial Burden of Food Allergy Among Adults: A US Population-Based Study	25
Quantification of Glucocorticoid-Associated Morbidity in Severe Asthma Using the Glucocorticoid Toxicity Index	25
Efficacy of Subcutaneous and Sublingual Immunotherapy for House Dust Mite Allergy: A Network Meta-Analysis–Based Comparison	24
Food-Induced Anaphylaxis in Infants: Can New Evidence Assist with Implementation of Food Allergy Prevention and Treatment?	24
Allergy Evaluation of Hypersensitivity to Platinum Salts and Taxanes: A Six-Year Experience	24
Direct Challenges for the Evaluation of Beta-Lactam Allergy: Evidence and Conditions for Not Performing Skin Testing	24
Sleep Disturbance in School-Aged Children with Atopic Dermatitis: Prevalence and Severity in a Cross-Sectional Sample	24
COVID-19 Pandemic–Related Reductions in Pediatric Asthma Exacerbations Corresponded with an Overall Decrease in Respiratory Viral Infections	24
Cost-Effectiveness of Biologics for Allergic Diseases	24
Balancing Cancer Immunotherapy Efficacy and Toxicity	24
Vaccine Hesitancy: Drivers and How the Allergy Community Can Help	24
Delabeling Delayed Drug Hypersensitivity: How Far Can You Safely Go?	24
Anaphylaxis to sugammadex-rocuronium inclusion complex: An IgE-mediated reaction due to allergenic changes at the sugammadex primary rim	24
African American Children Are More Likely to Be Allergic to Shellfish and Finfish: Findings from FORWARD, a Multisite Cohort Study	24
Efficacy of House Dust Mite Sublingual Immunotherapy in Patients with Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial	24
The Role of In Vivo and Ex Vivo Diagnostic Tools in Severe Delayed Immune-Mediated Adverse Antibiotic Drug Reactions	24
Benralizumab for severe DRESS in two COVID-19 patients	24
“COVID Arm”: Very delayed large injection site reactions to mRNA COVID-19 vaccines	24
The Utility of Measuring Urinary Metabolites of Mast Cell Mediators in Systemic Mastocytosis and Mast Cell Activation Syndrome	24
Preventive Effect of Allergen Immunotherapy on Asthma and New Sensitizations	24
Glycated Hemoglobin A1c, Lung Function, and Hospitalizations Among Adults with Asthma	24
Synchronous Telemedicine in Allergy: Lessons Learned and Transformation of Care During the COVID-19 Pandemic	23